Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

IPSEN - 15 Year Stock Price History | IPSEY

Historical daily share price chart and data for IPSEN since 2010 adjusted for splits and dividends. The latest closing stock price for IPSEN as of July 16, 2025 is 30.54.
  • The all-time high IPSEN stock closing price was 41.10 on August 30, 2018.
  • The IPSEN 52-week high stock price is 32.16, which is 5.3% above the current share price.
  • The IPSEN 52-week low stock price is 25.66, which is 16% below the current share price.
  • The average IPSEN stock price for the last 52 weeks is 29.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
IPSEN Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 29.1913 28.6628 31.7321 25.3212 30.5400 8.02%
2024 29.2766 29.0987 33.6580 26.7303 28.2731 -2.85%
2023 28.9639 26.4866 33.7242 25.2848 29.1026 12.35%
2022 24.7535 21.1914 31.1704 20.5957 25.9041 18.67%
2021 22.9199 19.4952 26.7904 18.5448 21.8295 11.48%
2020 19.5317 20.6693 26.1881 9.3114 19.5819 -5.04%
2019 27.4981 28.8495 33.1176 19.8321 20.6218 -30.64%
2018 34.9862 27.9151 41.1043 27.9151 29.7299 6.93%
2017 27.0257 16.8736 32.8077 16.8736 27.8035 68.97%
2016 13.9556 14.4273 16.4548 11.7881 16.4548 11.02%
2015 12.8622 11.2300 15.5447 10.3421 14.8210 29.61%
2014 10.0161 9.9731 11.7952 8.5205 11.4348 12.45%
2013 7.9932 6.1267 10.1939 6.1267 10.1690 67.39%
2012 5.0934 5.0872 6.2545 4.3884 6.0749 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.239B $3.868B
Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.33
Zoetis (ZTS) United States $67.467B 25.17
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $44.157B 22.63
BeOne Medicines - (ONC) Cayman Islands $30.596B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.886B 0.00
Summit Therapeutics (SMMT) United States $20.995B 0.00
Merck (MKKGY) Germany $16.698B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.449B 11.90
Neurocrine Biosciences (NBIX) United States $13.210B 45.25
Orion OYJ (ORINY) Finland $10.973B 29.68
Stevanato Group S.p.A (STVN) Italy $7.732B 47.28
Corcept Therapeutics (CORT) United States $7.725B 62.80
Madrigal Pharmaceuticals (MDGL) United States $7.659B 0.00
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.807B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.310B 0.00
Hypermarcas (HYPMY) Brazil $3.178B 20.91
Crinetics Pharmaceuticals (CRNX) United States $2.987B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.589B 14.00
Catalyst Pharmaceuticals (CPRX) United States $2.583B 9.05
NewAmsterdam Pharma (NAMS) Netherlands $2.349B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.090B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Ocular Therapeutix (OCUL) United States $1.792B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.315B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.196B 23.92
Ardelyx (ARDX) United States $1.101B 0.00
ProKidney (PROK) United States $1.092B 0.00
Dyne Therapeutics (DYN) United States $1.061B 0.00
Enliven Therapeutics (ELVN) United States $1.053B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.024B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.982B 0.00
Xeris Biopharma Holdings (XERS) United States $0.823B 0.00
KalVista Pharmaceuticals (KALV) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.751B 0.00
Zevra Therapeutics (ZVRA) United States $0.674B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.624B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.583B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Bioventus (BVS) United States $0.545B 13.83
Siga Technologies (SIGA) United States $0.484B 10.12
Tourmaline Bio (TRML) United States $0.476B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.399B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.345B 9.31
Altimmune (ALT) United States $0.339B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.308B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Nektar Therapeutics (NKTR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.246B 0.00
OmniAb (OABI) United States $0.242B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.197B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.140B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Korro Bio (KRRO) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Jupiter Neurosciences (JUNS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 43.11
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.57
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00